In Phase II-IV

PharmaNet offers all the clinical development services traditionally associated with conducting Phase II-IV programs. A key differentiating factor of PharmaNet is that in every program we conduct, PharmaNet provides an unrivaled combination of experienced project-management teams, senior management oversight, and an exclusive approach to building relationships with sponsors.

Women’s Health

PharmaNet offers a dedicated team of professionals focused solely on the clinical investigation of pharmaceuticals, biologicals, and medical devices that hold promise for improving women’s health. Team members include clinicians, project managers, clinical research associates, data analysts, biostatisticians, and medical writers. PharmaNet professionals provide expertise in a broad range of therapeutic areas relating to women’s health, including:

Osteoporosis Contraception
Hormonal therapies Urinary incontinence
Sexual dysfunction Fertility
Breast implantation Pregnancy and labor
Uterine disorders Menstrual disorders
Hypercholesterolemia Breast carcinoma
Gynecological infections Gynecological malignancies
In vitro fertilization  

 


Phillippa Smit-Marshall, MD

Executive Medical Director, Europe and Asia-Pacific

Dr. Smit-Marshall is a pharmacologist and general physician, with a specialty in women's health. She has more than 20 years of experience in pharmaceutical medicine, including service as European Product Director, Women's Health and Endocrinology for Quintiles Europe. Dr. Smit-Marshall has also held senior-level Medical Director positions at Zambon and Novo Nordisk and she worked on global clinical development initiatives at Glaxo Pharmaceutical and then at SmithKline Beecham (now GlaxoSmithKline).

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390